ロード中...
LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS
Pediatric lower grade glioma (LGG) can cause significant morbidity and mortality in patients. Tumors often initially respond to first line chemotherapies, such as carboplatin, but approximately 50% of the time tumors recur and require additional therapy. The discovery that aggressive LGG often have...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475104/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|